Revenues of Design Therapeutics, Inc. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Design Therapeutics, Inc. annual and quarterly Revenues in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • Design Therapeutics, Inc. Revenues for the quarter ending 31 Mar 2025 was $0.
  • Design Therapeutics, Inc. annual Revenues for 2025 was $0.
Source SEC data
View on sec.gov
Revenues, Annual (USD)
Revenues, Quarterly (USD)

Design Therapeutics, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 $0 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $0 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2025 2024 FY

Design Therapeutics, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.